document type sequence filename description text html head head body bgcolor ffffff link blue vlink purple style font family time roman align right style margin text align right font size face time roman style font size font weight bold exhibit nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold business confidential information font style margin font size face time roman style font size nbsp font align right style margin text align right font size face time roman style font size font weight bold text omitted filed separately with security exchange commission font align right style margin text align right font size face time roman style font size font weight bold confidential treatment requested under section nbsp font align right style margin text align right font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license font font size style font size font weight bold agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size between font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold adaptimmune limited font align center style margin text align center font size face time roman style font size licensee font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold life technology corporation font align center style margin text align center font size face time roman style font size licensor font style margin font size face time roman style font size nbsp font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size license agreement font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this license agreement hereinafter called license effective effective date between adaptimmune limited incorporated united kingdom whose registered office garsington road oxford business park oxford with place business milton park abingdon oxon united kingdom adaptimmune life technology corporation delaware corporation whose headquarters located allen carlsbad each adaptimmune party hereunder collectively referred party font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size witnesseth font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas owns patent right defined below licensed cell method defined below which willing license adaptimmune accordance with provision this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas control right licensed monoclonal antibody defined below which willing sublicense adaptimmune accordance with provision this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas adaptimmune wish acquire exclusive license under patent right licensed monoclonal antibody manufacture import offer sale sale licensed cell product defined below licensed territory defined below field defined below accordance with provision this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size therefore accordance with extent provided aforementioned authority consideration foregoing premise covenant obligation hereinafter forth well truly performed other good valuable consideration party hereto agree foregoing follows font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size definition font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size following definition shall apply defined word where such word used this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size affiliate mean with respect nbsp business entity controlling controlled under common control with nbsp adaptimmune business entity controlled adaptimmune where control mean possession direct indirect power direct cause direction management policy entity whether through ownership voting security contract otherwise notwithstanding foregoing person entity that would otherwise qualify affiliate hereunder foregoing definition shall deemed shall treated affiliate nbsp primary business such person entity investing security debt other investment vehicle nbsp such person entity portfolio company person entity that satisfies font style margin font size face time roman style font size nbsp font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size criterion under clause effective date adaptimmune nbsp affiliate named adaptimmune which incorporated united state purpose this license nbsp immunocore limited affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amended restated agreement mean that certain amended restated license agreement between fhcrc dated october nbsp pursuant which granted right licensed monoclonal antibody licensed cell line font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune improvement patent mean patent right arising from improvement made controlled adaptimmune font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size approval obtained mean with respect product process that sale such product process field country been licensed cleared approved applicable regulatory other governmental authority such country including food drug administration with respect product process sold united state font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size autoimmune disease mean condition disease which there immune system dysregulation whereas inappropriate immune response against normal tissue present body such that immune system recognizes such normal tisuues cell self font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size cancer mean malignant neoplasm involving unregulated cell growth which able invade other tissue nbsp specific neoplastic indication listed section nbsp subsection subsection international classification disease ninth revision clinical modification font style margin font size face time roman style font size http chrisendres index action child recordid font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size change control mean with respect party nbsp sale lease other disposition substantially asset right business sale substantially intellectual property each transaction series transaction acquisition such party merger consolidation reorganization business combination event party into with another entity which stockholder such party immediately prior such event after such event majority outstanding voting share surviving purchasing newly resulting business entity merger transaction nbsp transaction series related transaction which party party which excess fifty percent such party voting power transferred provided however consolidation business combination merger effected exclusively change domicile party issuance share party transaction whose primary purpose raise capital such party involve merger transaction shall deemed change control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean third party manufacturer with whom adaptimmune entered into written agreement such third party manufacturer manufacture certain product solely behalf adaptimmune font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size restriction meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size commercial developer meaning forth font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size commercial development plan mean that commercial development plan development marketing licensed cell product attached exhibit nbsp hereto font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size discloser meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size effective date this license shall mean december nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size engineered cell receptor mean alpha beta cell receptor such that cell engineering platform provides cell which just have their endogenous gene have been transduced with gene expression alpha beta cell receptor this being defined protein that contains alpha variable domain beta variable domain either which wild type sequence mutated amino acid position font style margin font size face time roman style font size nbsp font style margin punctuation wrap simple text indent font size face time roman style font size font font size style font size font font size style font size field mean vivo activation expansion human cell containing engineered cell receptor therapy treatment cancer nbsp infectious disease autoimmune disease where such therapy comprises nbsp removing sample containing cell from human patient nbsp isolating cell from such sample using bead product similar magnetic bead nbsp transfecting such isolated cell with gene gene encoding engineered cell receptor known antigen specificity nbsp activating expanding population such engineered cell using bead product similar magnet bead nbsp introducing expanded engineered cell back into same patient treatment such cancer nbsp infectious disease autoimmune disease font style margin punctuation wrap simple font size face time roman style font size nbsp font style margin punctuation wrap simple font size face time roman style font size understood agreed that field style font style italic font weight bold would include nbsp activation expansion cell modified through gene transfer specifically modify cell produce secreted cell surface membrane bound protein normally expressed significant level such cell unless protein enable selection modify preserve function cell nbsp developing making using selling offering sale pharmaceutical product containing ctla mutant thereof avoidance doubt this field restriction apply activation expansion cell modified through gene transfer with engineered cell receptor font style margin punctuation wrap simple font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size fhcrc mean fred hutchinson cancer research center font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size improvement mean improvement technology claimed patent right which nbsp subject patent application which dominated issued patent within patent right nbsp practiced without claim patent right font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size infectious disease mean transmissible disease communicable disease resulting from infection presence growth pathogenic organism within individual host organism font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size information mean with respect party hereto information marked proprietary business proprietary business confidential information other equivalent designation that such party discloser provides other party recipient reasonably considers confidential proprietary trade secret nature including financial statement projection technical report royalty report customer supplier information research design plan compilation method technique process procedure clinical data patent application information pertaining regulatory filing know whether tangible intangible form term condition this license shall information party between party commercial development plan exhibit nbsp hereto report notice provided adaptimmune hereunder shall information adaptimmune whether marked forth above notwithstanding foregoing nbsp information party shall include information that recipient establish record font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp within public domain prior time receipt recipient thereafter becomes within public domain other than result disclosure recipient representative violation this license font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp before date disclosure possession recipient font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp acquired recipient from third party having right disclose without burden confidentiality font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp hereafter independently developed recipient font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size bead product mean certain licensed product which commercially available dynabeads magnetic bead product made under good manufacturing practice currently offered sale sold otherwise distributed distributed affiliate their respective distributor under trade name dynabeads future improved commercially available version foregoing font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size improvement patent mean patent right arising from improvement made controlled font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size patent right mean font font size style font size more patent patent application listed exhibit nbsp improvement patent font font size style font size patent issuing from patent patent application therein together with reissue reexamination certificate extension supplementary protection certificate other governmental which effectively extend period exclusivity patent holder substitution confirmation registration revalidations addition continuation division continuation part patent addition extent claim entitled priority foregoing font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size foregoing foreign counterpart filed issued licensed territory font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licensed cell line mean hybridoma cell line described anasetti induction specific nonresponsiveness unprimed human cell anti antibody alloantigen anasetti treatment acute graft versus host disease with nonmitogenic anti monoclonal antibody transplantation progeny clone derivative modification thereof such derivative modification shall include antibody which derived from developed using licensed cell line licensed monoclonal antibody collectively licensed material which have been entirely made with information material available public domain font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licensed cell method mean method practice which would grant license herein infringe more valid claim patent that within patent right whether method practice includes bead product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size licensed monoclonal antibody mean monoclonal antibody antigen binding fragment thereof produced derived from licensed cell line font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size licensed cell product mean product comprised containing engineered cell receptor nbsp which isolated activated expanded licensed product nbsp manufacture offer sale import sale which would grant license herein infringe covered more valid claim patent that within patent right nbsp used with licensed cell method nbsp produced processed otherwise manufactured using with licensed cell method font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licensed product mean cell product including reagent device package that contain derived from result from licensed monoclonal antibody including without limitation bead coated with licensed monoclonal antibody either itself combination with other antibody clarity licensed product include licensed cell line licensed cell product licensed product include bead product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licensed territory mean country world which patent right exist font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size milestone payment shall have meaning ascribed section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size minimum annual royalty shall have meaning ascribed section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size selling price mean amount billed invoiced adaptimmune affiliate sale licensed cell product deduction nbsp import export excise sale value added custom duty font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style margin font size face time roman style font size nbsp font style margin font size face time roman style font size freight insurance invoiced paid purchaser such licensed cell product nbsp rebate trade discount customarily actually allowed other than advertising allowance commission employee adaptimmune affiliate nbsp credit return allowance trade actually granted font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size transfer licensed cell product adaptimmune affiliate subsequent resale shall constitute sale third party provided however those revenue from sale licensed cell product affiliate internal commercial shall included determination selling price font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size there shall imputed revenue from nbsp promotional free sample free good other marketing program whereby licensed cell product provided free charge promote sale nbsp licensed cell product nbsp compassionate where treatment seriously patient using unapproved investigational drug when other treatment available nbsp physician sponsored investigational drug application furthermore until such time licensed cell product been licensed approval obtained applicable regulatory authority given country transfer such licensed cell product that country testing clinical clinical developmental purpose shall included calculation selling price hereunder only extent that consideration received such licensed cell product exceeds cost such licensed cell product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size other agreement mean certain license agreement between adaptimmune effective december nbsp under which license certain right adaptimmune pursuant that certain exclusive license agreement among licensee united state department navy naval medical research center regent university michigan dana farber cancer institute nbsp effective september nbsp amended navy sublicense font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size pivotal trial mean pivotal registration study equivalent thereof purpose obtaining regulatory approval clearance jurisdiction determined confirmed applicable regulatory authority market sell licensed cell product within field font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size recipient meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size term mean period commencing effective date ending expiration last expire patent patent right font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size third party mean person entity that nbsp party this license nbsp affiliate party this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size treatment mean pharmacological method ameliorating curing cancer autoimmune disease infectious disease font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size united state mean united state america territory possession district columbia commonwealth puerto rico font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size valid claim mean nbsp claim unexpired patent which shall have been withdrawn canceled disclaimed held invalid unenforceable court competent jurisdiction unappealed unappealable decision nbsp claim patent application which either nbsp subject pending patent interference proceeding nbsp supported disclosure such application prior filed patent application cumulative period exceeding seven nbsp year from earliest date such supporting disclosure such claim such patent application font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size interpretation this license unless context indicates contrary intention font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size person includes individual estate individual corporation authority association joint venture whether incorporated unincorporated partnership trust other entity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size reference party includes that party executor administrator successor permitted assigns including person taking novation case trustee includes substituted additional trustee font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size reference document including this license that document varied novated ratified replaced from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size reference statute statutory provision includes statutory modification enactment statutory provision substituted each ordinance regulation rule nbsp statutory instrument however described issued under font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size reference party clause schedule exhibit attachment annexure reference party clause schedule exhibit attachment annexure this license reference this license includes schedule exhibit attachment annexures font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size word phrase given defined meaning other part speech grammatical form that word phrase corresponding meaning font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size whenever this license refers number such number shall refer calendar unless business specified business mean except saturday sunday which commercial banking institution york york open business font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size includes form word limitation shall deemed followed phrase limited without limitation word similar import font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size disjunctive necessarily exclusive font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size reference dollar united state currency font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size grant font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size effective date subject term condition this license hereby grant adaptimmune subject section nbsp affiliate specified section nbsp herein adaptimmune hereby accepts font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size exclusive subject section sublicensable except forth section transferable except forth section nbsp license under font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size patent right nbsp practice have practiced licensed cell method solely make have made licensed cell product solely field licensed territory each case solely adaptimmune third party manufacturer solely behalf adaptimmune subject certain restriction including those forth below section nbsp nbsp have used offer sale have offered sale sell have sold import have imported licensed cell product solely field licensed territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size exclusive sublicensable transferrable except forth section nbsp sublicense licensed product make have made sell licensed cell product field right granted licensed cell line font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp clarification purpose license grant forth this section nbsp specifically exclude right adaptimmune affiliate cmos make have made offer sale have offer sale sell have sold licensed cell line licensed product licensed monoclonal antibody bead product other product adaptimmune affiliate cmos expressly prohibited from using licensed monoclonal antibody licensed cell line purpose other than part licensed product expressly described this license additional clarification purpose shall transfer licensed monoclonal antibody licensed cell line adaptimmune hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size license grant section nbsp adaptimmune affiliate listed section nbsp shall deemed sublicensee such affiliate shall subject separate initial license minimum annual royalty payment obligation provided that such affiliate shall subject payment obligation which paid directly such affiliate paid adaptimmune based such affiliate sale hereunder with respect such affiliate running royalty accordance with section nbsp milestone payment accordance with section nbsp such grant subject following nbsp such affiliate directly indirectly controlled foreign united state government nbsp each such affiliate agreed writing comply with term condition this license adaptimmune provides notice copy foregoing nbsp breach this license affiliate adaptimmune shall deemed breach this license adaptimmune such affiliate font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune will notify licensed cell product user purchaser require affiliate likewise label license product literature accompanying licensed cell product that licensed cell product prohibited nbsp activation expansion cell modified through gene transfer specifically modify cell produce secreted cell surface membrane bound protein normally expressed significant level such cell unless protein enable selection modify preserve function cell nbsp developing making using selling offering sale pharmaceutical product containing ctla font align center style margin punctuation wrap simple text align center font size face time roman style font size nbsp font align center style margin punctuation wrap simple text align center font size face time roman style font size name _pb_ font style margin punctuation wrap simple size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin punctuation wrap simple font size face time roman style font size nbsp font style margin punctuation wrap simple font size face time roman style font size mutant thereof avoidance doubt label license purchaser state that activation expansion cell modified through gene transfer purchaser using adaptimmune engineered cell receptor authorized licensed cell product field this section nbsp limit definition licensed cell product font style margin punctuation wrap simple font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune understands acknowledges agrees that license under patent patent application other than patent right including with respect other patent intellectual property which control under know shall deemed have been granted under this license either expressly implication font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size this license assignable adaptimmune without prior written approval except connection with assignment this license other agreement third party acquirer pursuant change control provided that such assignment shall obligate adaptimmune refundable creditable assignment which such assignment shall payable within thirty such assignment adaptimmune shall provide with written notice such permitted assignment time such assignment other assignment this license adaptimmune shall contingent prior written approval which such approval shall unreasonably withheld notwithstanding foregoing shall provide response adaptimmune request such written approval within thirty receipt request event assignment this license party which adaptimmune assigns this license other agreement shall agree writing assume responsibility obligation adaptimmune under this license other agreement further assignment transfer this license other agreement permitted without prior written permission which such approval shall unreasonably withheld font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune shall have right designate written notice which includes applicable contact information third party whom granted license similar right under intellectual property field specific licensed cell product upon such designation shall make available such designee without being considered breach this license license right patent right field same term condition including without limitation minimum annual royalty milestone payment royalty other financial consideration described this license agreement nbsp entered into between each such designee clarity nbsp event adaptimmune designee enters into license with pursuant this section nbsp nbsp milestone payment nbsp will from party adaptimmune designee applicable that achieve nbsp each such milestone event there shall royalty owed selling price licensed cell product such party adaptimmune designee sold licensed cell product specified section nbsp nbsp requested adaptimmune shall provide license designee nbsp that includes right beyond specific licensed cell product extent that adaptimmune hold such right under this license term offered designee font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size licensee shall favorable such designee nbsp than those provided adaptimmune herein unless third party designated adaptimmune pursuant this section nbsp breach agreement with dispute resolution arbitration mediation litigation with time such third party designated refuse offer grant license right patent right field third party that designated designee pursuant this section nbsp adaptimmune exactly same term condition forth this license font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size adaptimmune performance font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune will require will require each adaptimmune affiliate with whom extends right under this license pursuant section nbsp require each such adaptimmune affiliate wish engage practice licensed cell method bead product make licensed cell product solely field behalf adaptimmune have entered into written executed agreement with adaptimmune such adaptimmune affiliate that nbsp allows such licensed cell method bead product make licensed cell product solely field adaptimmune affiliate authorized pursuant section nbsp adaptimmune such adaptimmune affiliate sponsored clinical trial supporting regulatory approval such licensed cell product thereafter commercial sale adaptimmune authorized adaptimmune affiliate collectively purpose nbsp allows such make licensed cell product solely purpose nbsp prohibits such from transferring bead product licensed cell product using bead product licensed cell product behalf third party nbsp prohibits such from using bead product licensed cell product licensed cell method patent right benefit such other than such behalf adaptimmune authorized adaptimmune affiliate purpose nbsp requires such return adaptimmune certify such return writing destroy certify such destruction writing adaptimmune discretion bead product licensed cell product possession upon completion termination activity behalf adaptimmune such authorized adaptimmune affiliate with copy such certification provided upon request collectively restriction agrees that within herein license grant section adaptimmune authorized adaptimmune affiliate permitted enter into agreement forth this section nbsp using other than permitted under this license bead product licensed cell product licensed cell method patent which were provided such adaptimmune authorized adaptimmune affiliate pursuant this license shall violation agreement adaptimmune will immediately notify writing once becomes aware itself through third party that violation agreement will promptly notify font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size such writing that such violation agreement adaptimmune agrees that affiliate continued employment that violation agreement conditioned curing status being violation agreement within thirty transmission written notice that status adaptimmune that adaptimmune adaptimmune affiliate continues employment that status cured within this specified timeframe that shall constitute material breach adaptimmune this license which terminate this license pursuant section nbsp nbsp immediately adaptimmune terminates agreement because violation agreement such shall immediately cease activity under agreement such prohibitted from continuing completing activity which been actually initiated planned under agreement time termination adaptimmune need continue complete that which been actually initiated under agreement time termination deliver same following said termination adaptimmune shall make such request writing shall consider consenting such request sole reasonable discretion notwithstanding foregoing adaptimmune responsible performance performance each affiliate their cmos under pursuant this license sake clarity adaptimmune sole adaptimmune affiliate purpose this paragraph font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune will reasonable commercial effort carry commercial development plan scientific business judgment develop commercialize licensed cell product adaptimmune shall report such effort accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune agrees report within twenty adaptimmune discontinuance making benefit patent right licensed cell method reasonably accessible united state public font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size during term this license each calendar year prior first commercial sale licensed cell product adaptimmune affiliate adaptimmune agrees expend nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp research development directly relating commercialization licensed cell product during term addition section nbsp acknowledges agrees that adaptimmune spends than nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp research development directly relating commercialization licensed cell product pursuant other agreement defined therein adaptimmune shall have satisfied diligence obligation pursuant this section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune fails demonstrate reasonable commercial effort required section above provide written notice adaptimmune specifying basis such notice upon receipt such notice adaptimmune shall font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size develop provide written plan cure such failure within ninety receipt such notice adaptimmune will mutually agree upon timetable performance such cure plan adaptimmune fails diligently implement such written cure plan shall entitled provide written notice terminate this license such failure cured within ninety period following receipt such notice notwithstanding foregoing shall unreasonably withhold consent revision time period under commercial development plan whenever requested writing adaptimmune supported evidence technical difficulty delay regulatory process that outside adaptimmune reasonable control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size upon first commercial sale licensed cell product adaptimmune will deemed have satisfied diligence obligation under section adaptimmune will thereafter continue make benefit licensed cell product reasonably accessible public remainder term this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event adaptimmune purchase bead product adaptimmune will purchase such bead product only from designated affiliate pricing specification bead product will commercially reasonable mutually agreed upon party party agree negotiate such pricing specification good faith font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune licensed product licensed monoclonal antibody make have made sell licensed cell product subject following policy obligation condition fred hutchinson cancer research center patent invention policy adopted september nbsp public fhcrc obligation under agreement with other sponsor research right granted this license amended restated agreement greater than that permitted under public shall subject modification required conform provision statute font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size improvement improvement made controlled adaptimmune including adaptimmune improvement patent shall owned adaptimmune adaptimmune shall promptly disclose adaptimmune improvement patent improvement made shall owned shall promptly disclose adaptimmune improvement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune hereby grant option execute exclusive worldwide royalty bearing license with right grant further sublicenses under adaptimmune improvement patent make have made have used sell have sold offer sell import have imported practice have practiced product manufacture sale offer sale importation which covered valid claim adaptimmune improvement patent country manufacture sale offer sale import territory outside field subject sublicensee paying adaptimmune commercially reasonable royalty rate sale product other consideration including license milestone negotiated font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size good faith notwithstanding foregoing extent that sublicensee wish have right grant further sublicense pursuant term condition this section nbsp adaptimmune agrees enter into good faith negotiation with designee consent such request font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size bead product extent that adaptimmune affiliate purchase bead product under research only label nbsp adaptimmune shall shall cause affiliate comply with transfer restriction under such applicable label license nbsp such bead product shall used make have made licensed cell product under this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size extent that adaptimmune affiliate wish purchase bead product connection with clinical trial commercialization licensed cell product each adaptimmune hereby agree negotiate good faith enter into commercially reasonable supply agreement supply bead product custom adaptiummune variation thereof such supply agreement will include commercially reasonable pricing forecasting warranty other commercially reasonable customary term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size accordance with exclusive nature this license under section nbsp from effective date during term this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp shall modify limited label license associated with bead product clearly state that there explicit implied license purchaser under patent right with respect commercial commercially sponsored profit third party activity involving engineered cell receptor product field that only strictly academic profit commercially sponsored third party research involving engineered cell receptor product field permitted font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp third party engaging commercial commercially sponsored profit activity involving engineered cell receptor product field commercial developer shall knowingly provide commercial developer bead product activity involving engineered cell receptor product field within patent right shall knowingly provide commercial developer drug master file cross reference authorization letter concerning bead product involving engineered cell receptor product field within patent right either case without adaptimmune prior written permission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size restriction font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size from effective date during term this license agrees that shall knowingly directly explicitly impliedly license offer license licensed cell method patent right commercial developer making having made using having used selling having sold offering sell having offered sell imported having imported exported having exported licensed cell product field font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size without express written permission adaptimmune shall knowingly directly assist commercial developer with interaction with regulatory agency whose approval required marketing licensed cell product field including without limitation united state food nbsp drug administration european medicine agency emea medicine healthcare product regulatory agency mhra with respect such commercial developer activity before such regulatory agency obtain approval market licensed cell product field with understood that such activity include without limitation application application clinical trial activity such without limitation nbsp investigational drug application drug application abbreviated drug application anda biologic license application program application request conduct clinical trial like font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size breach provision section nbsp nbsp shall considered material breach this license which adaptimmune shall provide written notice which specifies such breach detail provide thirty cure such breach font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size patent challenge subject section nbsp adaptimmune affiliate brings support directly indirectly challenge claim position before judicial administrative body other governmental forum asserting supporting that claim patent right invalid unenforceable including part litigation examination opposition interference issue proceeding outcome such challenge claim position that such claim patent right valid enforceable then nbsp running royalty rate forth section nbsp minimum annual royalty obligation under section nbsp shall increase amount provided therein nbsp adaptimmune shall reimburse attorney incurred affiliate connection with such challenge claim position this section nbsp shall apply assertion failure consideration action proceeding subject section nbsp which adaptimmune defending against assertion breach this license asserting breach this license font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size royalty other consideration report font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size license issue font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size partial consideration right granted adaptimmune hereunder adaptimmune shall refundable creditable license issue amount three hundred thirty five thousand dollar license issue such license issue payable adaptimmune within fifteen effective date font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size minimum annual royalty font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size during term this license adaptimmune shall refundable minimum annual royalty minimum annual royalty nbsp each full partial calendar year during which there approval obtained licensed cell product nbsp first full calendar year year following date that there approval obtained thereafter refundable minimum annual royalty that equal fifty percent adaptimmune earned running royalty sale adaptimmune affiliate such licensed cell product previous calendar year minimum annual royalty will fully creditable against running royalty payable adaptimmune affiliate account running royalty under section nbsp applicable calendar year which such minimum annual royalty relates shall creditable against milestone payment defined section nbsp made time difference between minimum annual royalty particular calendar year running royalty payable such calendar year will paid along with royalty payment royalty report fourth font font size style font size position relative font font size style font size quarter each calendar year within forty five each december nbsp accordance with section nbsp clarification purpose minimum annual royalty refundable whole part font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size running royalty font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp adaptimmune shall royalty percent selling price each licensed cell product sold adaptimmune affiliate authorized third party designees pursuant section nbsp licensed territory during term accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp adaptimmune party patent other technology license agreement with third party which license employed manufacture sale licensed cell product adaptimmune reduce royalty rate applicable hereunder each royalty rate payable such third party long selling price sale upon which royalty based substantially similar definition selling price herein provided however that event will royalty rate otherwise licensed cell product reduced than percent such other license includes royalty stacking provision like intent this section nbsp royalty rate reduction provided this section nbsp nbsp will calculated such provision such other license were absent font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp event that adaptimmune sell product that would considered licensed cell product under this license also licensed cell product under navy sublicense adaptimmune shall running royalty selling price such product required under each this license navy sublicense applicable clarification section nbsp nbsp shall font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size apply such situation except extent that third party license license employed manufacture sale such product example adaptimmune sell product that licensed cell product under this license licensed cell product under navy sublicense then adaptimmune shall running royalty under this license under navy sublicense selling price such product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp adaptimmune obligation royalty sale cell product shall terminate country country basis upon expiration last expire patent right each country event that country claim within patent right that cover particular cell product held invalid unenforceable unappealed unappealable order then adaptimmune obligation royalty with respect such cell product shall terminate such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp royalty will paid shall they charged collected cell product sold directly instrumentality united state government such sale licensed cell product with established list catalog price shall have their price reduced amount equal that part established price attributable royalty that would otherwise hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size milestone payment font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp each licensed cell product adaptimmune will make payment milestone payment manner prescribed this section nbsp section nbsp accordance with following schedule with respect following event each milestone event sponsored adaptimmune affiliate font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width colspan valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold amount nbsp payable font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff border none border solid windowtext padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align right style margin text align right font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size with respect licensed cell product which milestone payment been made adaptimmune shall have obligation make same milestone payment when make filing including amendment applicable biological license application obtains approval related same licensed cell product having same active ingredient indication additional indication which first milestone payment nbsp such licensed cell product were made font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size method payment report documentation font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp adaptimmune shall send running royalty hereunder within thirty following applicable calendar quarter subject section nbsp final running royalty payment hereunder shall thirty after expiration termination this license royalty payment shall accompanied sale report accordance with section nbsp sent accordance with section nbsp other payment including milestone payment shall accompanied appropriate documentation explain basis payment calculated sent accordance with section nbsp adaptimmune shall milestone payment within thirty milestone event within thirty effective date this license such milestone event been completed adaptimmune prior effective date this license payment sent wire term accompanied preceding sentence shall satisfied contemporaneous delivery such documentation accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amount payable hereunder adaptimmune shall payable united state dollar paid wire transfer check bank draft other mutually acceptable manner date payment made wire adaptimmune shall responsible bank transfer charge transfer will include specific reference this license applicable provision comment field font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size wire instruction font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size bank name font font size style font size font font size style font size font style margin font size face time roman style font size bank address font font size style font size font font size style font size font style margin font size face time roman style font size font style margin font size face time roman style font size font font size style font size font font size style font size font style margin font size face time roman style font size telex font font size style font size font font size style font size font style margin font size face time roman style font size credit font font size style font size font font size style font size font style margin font size face time roman style font size account number font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size payment check bank draft shall made font style margin font size face time roman style font size font style margin font size face time roman style font size font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size conversion foreign currency shall accordance with united state generally accepted accounting principle standard practice adaptimmune using exchange rate from source that generally accepted industry such wall street journal major united state bank such payment shall without deduction exchange collection other charge specifically without deduction government imposed except permitted definition selling price except withholding extent applicable font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size late payment font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size payment made adaptimmune after date shall include interest rate percent month further minimum annual royalty timely paid this license terminate accordance with article nbsp payment together with accrued interest surcharge percent minimum annual royalty paid before expiration cure period forth article nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size payment such interest shall foreclose from exercising other right have consequence lateness payment font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size retention record font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune agrees make keep shall require affiliate make keep commercially reasonable full accurate complete book record together with supporting documentation necessary establish compliance with this article nbsp identify licensed affiliate referred section nbsp such record shall retained least year following calendar year which they relate font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size audit font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune agrees that upon commercially reasonable notice during adaptimmune normal business hour desire future time time more often than once every twelve month have duly authorized agent font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size representative behalf examine book record supporting documentation described preceding section either adaptimmune business premise place mutually agreed upon adaptimmune sole purpose verifying report payment hereunder conducting examination pursuant this paragraph representative shall have access record that reasonably belief relevant calculation royalty other payment under article nbsp payment deficiency determined adaptimmune shall deficiency outstanding within thirty receiving written notice thereof payment made adaptimmune after date shall include interest rate percent month plus processing percent underpayment such examination representative shall expense except that such examination show underreporting underpayment excess percent font font size style font size font font size style font size twelve month period then adaptimmune shall cost such examination overpayment shall credited against future royalty payment representative shall required treat information received during such inspection information accordance with article nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size patent marking nonendorsement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune hereby agrees mark each licensed cell product under this license when character product precludes marking package containing such licensed cell product accordance with applicable preserve available patent right adaptimmune agrees create appearance that affiliate endorse adaptimmune business product agrees create appearance that adaptimmune affiliate endorse business product unless otherwise agreed writing party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size article nbsp font font size style font size font font size style font size disclaimer representation warranty acknowledgment font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size neither grant this license anything contained related grant this license intended shall construed confer upon either party other person immunity from defense under antitrust charge patent misuse other provision jurisdiction reason source grant otherwise font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size neither this license anything contained herein intended shall construed grant adaptimmune kind nature right invention patent other than patent right licensed cell method font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune representation warranty font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune acknowledges that only with respect this license activity undertaken pursuant right granted hereunder including without limitation sell have sold offer sale licensed cell product subject shall comply with applicable united state regulation executive order font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size pertaining patent right licensed cell method licensed product bead product other right granted hereunder make have made sell licensed cell product exporting from united state subject adaptimmune status being incorporated united kingdom identified outset this license adaptimmune shall export assist others export licensed cell product licensed product information including without limitationltc information related practice patent right licensed cell method without first nbsp having solely expense identified obtained required export license authorization nbsp having provided copy such export license authorization nbsp addition compliance with section nbsp having obtained prior written consent such information information extent that view adaptimmune status being incorporated united kingdom identified outset this license entering into performing under this license export under applicable united state regulation product information adaptimmune shall cause affiliate such affiliate expense identify obtain required export license authorization font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune represents warrant that obtained will time during term hold comply with license permit authorization necessary adaptimmune complete timely performance obligation under this license which required under applicable statute ordinance rule nbsp regulation united state well those applicable foreign governmental body agency subdivision having asserting claiming jurisdiction over adaptimmune adaptimmune performance term exercise affiliate right under this license particular adaptimmune font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size will responsible obtaining necessary united state food drug administration approval approval required similar governmental body agency applicable foreign country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size understands acknowledges that transfer certain commodity technical data subject united state regulation controlling export such commodity technical data including export administration regulation united state department commerce these regulation among other thing prohibit require license export certain type technical data certain specified country adaptimmune hereby agrees give written assurance that will comply with united state regulation controlling export commodity technical data that will solely responsible violation such adaptimmune affiliate that will defend hold affiliate fhcrc harmless event legal action nature occasioned such violation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size represents warrant that nbsp adaptimmune will resell licensed product bead product licensed monoclonal antibody nbsp adaptimmune affiliate applicable will conduct necessary test comply with applicable regulatory requirement obtain applicable font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size regulatory approval issue appropriate warning information user responsible obtaining required third party intellectual property right with respect adaptimmune affiliate nbsp patent right licensed cell method licensed product bead product other right granted hereunder make have made sell licensed cell product nbsp commercialization licensed cell product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size understands that there proprietary right owned third party that necessary desirable production commercialization licensed cell product adaptimmune agrees that nbsp securing access such third party right responsibility adaptimmune nbsp neither affiliate responsibility liability with respect such third party proprietary right this license confers license right implication estoppel otherwise under existing future patent application patent owned licensed affiliate other than those right contained patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size each party represents warrant other party that nbsp such party duly organized validly existing good standing under jurisdiction which organized nbsp such party legal power authority execute deliver perform this license nbsp execution delivery performance such party this license been duly authorized necessary action nbsp this license constitutes legal valid binding obligation such party enforceable against such party accordance with term nbsp execution delivery performance this license contravene material provision constitute material default under agreement binding such party nbsp execution delivery performance this license contravene material provision constitute material default under valid order court regulatory agency other body having authority which such party subject font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size pursuant section represents warrant that beginning effective date during term this license shall knowingly directly explicitly impliedly enter into agreement with third party that grant license such third party patent right make have made have used sell have sold offer sale have offered sale import have imported export have exported licensed cell product field notwithstanding foregoing adaptimmune acknowledges that entered into agreement with third party prior effective date this license where right were granted third party connection with sale bead product similar magnetic bead product such third party patent right make have made have used sell have sold offer sale have offered sale import have imported product including without limitation licensed cell product field font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size except expressly forth herein nbsp including this font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp none affiliate make representation extend warranty kind either express implied oral written arising course dealing course performance usage trade otherwise nbsp including limited implied warranty merchantability fitness particular purpose assume responsibility whatsoever with respect licensed cell line licensed monoclonal antibody licensed product licensed cell product design development manufacture sale other disposition adaptimmune affiliate licensed cell product licensed cell method adaptimmune affiliate assume entire risk design development manufacture sale performance licensed cell product licensed cell method font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size none affiliate make representation extends warranty kind either express implied that manufacture nbsp import offer sale sale other distribution authorized licensed cell line licensed monoclonal antibody licensed product licensed cell product licensed cell method shall infringe patent other right third party nothing this license shall construed warranty representation either affiliate validity enforceability patentability scope claim patent patent application within patent right grant either affiliate whether implication estoppel otherwise license right other than that expressly granted under section nbsp subject article nbsp obligation bring prosecute action suit against third party infringement patent right font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event shall either party affiliate liable hereunder other party nbsp affiliate other person entity special nbsp incidental consequential exemplary other indirect damage including loss profit loss damage arising this license from licensed cell line licensed monoclonal antibody licensed product manufacture nbsp import offer sale sale licensed cell product even such party been advised possibility such damage loss font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size article nbsp font font size style font size font font size style font size report font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size progress report font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune shall submit semi annual progress report adaptimmune effort carry commercial development plan develop commercialize licensed cell product first report nbsp month from effective date subsequent report shall made every nbsp month thereafter until such time licensed cell product been sold third party progress report shall describe detail adaptimmune effort toward carrying commercial development plan commercializing licensed cell product progress made expenditure incurred adaptimmune affiliate research development directed commercialization licensed cell product since date preceding report other information that adaptimmune agree pertinent commercialization effort subject proper marking required hereunder such report will constitute information adaptimmune font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size sale report font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune shall submit four nbsp quarterly sale report from date approval obtained licensed cell product including milestone event achieved during such time period such report detailing sale activity adaptimmune affiliate licensed cell product during preceding quarter include quantity sold identity patent right covering that licensed cell product selling price exchange rate used convert foreign currency united state dollar total amount running royalty other amount paid year quarterly sale report shall submitted regardless volume sale before each nbsp august nbsp november nbsp february nbsp most recent calendar quarter with royalty payment accordance with article nbsp final sale report thirty after expiration termination this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size prior date approval obtained licensed cell product adaptimmune shall submit four nbsp copy annual minimum annual royalty report milestone event report twelve month from effective date until date first approval obtained licensed cell product thereafter adaptimmune shall submit quarterly sale report according this section nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size method reporting font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size report under this article nbsp shall submitted font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size term termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size term font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size unless earlier terminated accordance with provision this article nbsp this license shall become effective effective date shall thereafter continue until expiration term font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size termination mutual agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size termination this license mutual agreement shall evidenced writing signed party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size termination this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size subject term this article nbsp this license terminated entirety provision termination notice indicating that font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size except case breach section nbsp which will governed section nbsp determined that adaptimmune demonstrate reasonable satisfaction that exercising commercially reasonable diligence reasonably commercialize licensed cell product accordance with term this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size adaptimmune willfully made false statement material fact report required this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size adaptimmune been found court competent jurisdiction final unappealable decision have violated federal antitrust other provision connection with performance under this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size determined that adaptimmune committed material breach covenant contained this license including without limitation section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size adaptimmune defaulted payment amount font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size described section nbsp extent allowable governing adaptimmune asserted invalidity unenforceability claim included patent right including litigation administrative proceeding either directly through affiliate third party font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size each case which violation adaptimmune fails cure forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size other ground termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size extent allowable governing font font size style font size ither party terminate this license other party subject insolvency event where insolvency event mean occurrence following nbsp nbsp party make assignment benefit creditor nbsp petition under foreign state united state bankruptcy receivership statute like they exist they amended filed party nbsp such petition filed with respect party third party application receiver made anyone with respect party such petition application successfully litigated unappealable appealed decision court final decisionor with respect party whereby petition application resolved favorably party within nbsp year from date such petition filed nbsp party cease doing business font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size procedure termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp before terminate this license reason other than mutual agreement pursuant section nbsp shall furnish adaptimmune written notice intention terminate stating reason nbsp therefor adaptimmune shall allowed sixty calendar thirty calendar with respect payment default after date notice remedy deficiency stated notice reason termination show cause this license should terminated font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune remedied deficiency stated notice within applicable notice period then this license shall terminate upon expiration notice period stated section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune right appeal accordance with procedure described section nbsp nbsp decision determination applicable concerning interpretation modification termination whole part this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size termination adaptimmune font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune terminate this license providing least thirty calendar written notice termination adaptimmune written notice shall specify effective date termination font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size minimum annual royalty termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this license shall automatically terminate midnight expiration thirty cure period commencing date receipt written notice minimum annual royalty calendar year together with interest surcharge that prescribed article nbsp been paid font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size effect termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size event termination this license adaptimmune affiliate shall nbsp have right nbsp month following date termination sell otherwise dispose stock licensed cell product subject this license then hand subject right receive payment report thereon provided herein nbsp return copy information fhcrc information within thirty date such termination shall delete such information fhcrc information from document data storage medium shall have officer adaptimmune certify compliance with foregoing font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size right obligation party forth herein that expressly their nature survive expiration termination this license including least provision this section nbsp article shall continue full force effect subsequent notwithstanding expiration termination this license until they satisfied their nature expire shall bind party their legal representative successor permitted assigns font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size notice font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notice required under this license shall considered timely made properly addressed nbsp time personally delivered nbsp transmission facsimile email confirmed notice other method described herein nbsp upon receipt sent commercial overnight delivery service font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size nbsp except otherwise provided section communication notice required made shall addressed follows font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size attn font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size attention font style margin text indent font size face time roman style font size telephone font style margin text indent font size face time roman style font size facsimile font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size with copy font font size style font size font font size style font size life technology corporation font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size attention font style margin text indent font size face time roman style font size telephone font style margin text indent font size face time roman style font size facsimile font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp communication notice required made adaptimmune shall addressed follows font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size telephone font style margin text indent font size face time roman style font size facsimile font style margin text indent font size face time roman style font size email font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp each adaptimmune agree report promptly other change mailing address name during term this license font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size article nbsp font font size style font size nbsp nbsp nbsp nbsp font font size style font size patent infringement font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size font font size style font size font font size style font size during term adaptimmune shall notify writing soon reasonably practical known suspected infringement unauthorized misappropriation nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp patent right field that discovered promptly shall provide with privileged confidential information supporting said infringement suspected infringement unauthorized misappropriation font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size case such known suspected infringement unauthorized misappropriation third party based activity authorized occurring prior effective date this license described section nbsp then adaptimmune shall confer with each other good faith regarding such alleged infringing activity preserving defending exclusive right granted hereunder adaptimmune font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that determines sole reasonable discretion that wish obtain additional information from adaptimmune investigate such matter then prior disclosure privileged confidential information regarding such matter adaptimmune will enter into agreement with that acceptable order protect such privilege party interest related thereto upon entering into such agreement shall have right request opinion counsel from adaptimmune detailing such alleged infringement specific information about such known suspected infringement unauthorized misappropriation shall cost obtaining each such opinion counsel such information determine sole reasonable discretion what action communication pursue against such third party font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size required bring maintain infringement action field against nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp adaptimmune shall join infringement action brought intended brought upon reasonable request with adaptimmune represented therein counsel sole selection reasonable cost adaptimmune shall reasonably cooperate enforcement action accordance with term condition specified with agreed that such cooperation adaptimmune represented therein counsel sole selection reasonable cost font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size specifically with respect only known suspected infringement activity nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp field that adaptimmune reasonably demonstrate will cause minimis monetary harm damage adaptimmune field adaptimmune provides written notice which specifically detail such harm damage harm notice then event that nbsp ninety passed from date receipt adaptimmune harm notice nbsp thirty passed from date receipt opinion counsel specified section nbsp whichever later caused such infringement cease desist taken continued pursuing action against third party with respect same including without limitation issuing cease desist notice with pursuing matter obtaining cease desist appealable judicial resolution then monies payment other consideration then owing adaptimmune hereunder shall what otherwise would payable hereunder modified financial obligation adaptimmune shall only liable modified financial obligation without breach termination this license penalty hereunder adaptimmune shall continue only liable modified financial obligation until such time caused such infringement cease desist become infringement obtaining cease desist third party subject agreement adaptimmune enters into sublicense becomes designee hereunder pursuant section nbsp appealable judicial resolution obtained which time thereafter until another harm notice event nbsp above described trigger again modified financial obligation adaptimmune shall again liable under original financial obligation specified herein adaptimmune failure perform original financial obligation specified herein shall considered breach adaptimmune this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that enters into license agreement with third party with respect patent right field including settlement known suspected infringement action proceeding infringement regardless whether commenced adaptimmune term more favorable than those herein those more favorable term shall immediately applicable adaptimmune this license shall amended incorporate those more favorable term font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that third party time provides written notice claim brings action suit proceeding against adaptimmune affiliate claiming infringement patent right unauthorized misappropriation know based assertion claim arising development manufacture distribution importation sale licensed cell product licensed cell method adaptimmune shall promptly notify claim commencement such action suit proceeding enclosing copy claim paper served font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size indemnification nbsp insurance legal action font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size indemnification adaptimmune font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune expense shall indemnify defend hold harmless respective affiliate respective officer director shareholder employee agent each foregoing each indemnified party from against liability damage loss expense including without limitation reasonable attorney expense litigation arbitration collectively liability incurred imposed upon indemnified party connection with third party claim suit action demand judgment each claim arising connection with resulting from nbsp design manufacture promotion sale other disposition licensed cell product practice licensed cell method adaptimmune affiliate nbsp actual alleged injury damage death other consequence occurring third party result directly indirectly practice licensed cell method adaptimmune affiliate customer transferee foregoing possession consumption licensed cell product sold adaptimmune affiliate regardless form which such claim made nbsp other activity carried adaptimmune affiliate pursuant this license nbsp failure representation warranty made adaptimmune this license true accurate except each case extent that such claim arises result from nbsp breach representation warranty herein nbsp gross negligence willful misconduct font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notice claim indemnified party entitled indemnification hereunder shall provide adaptimmune with prompt written notice claim which indemnification sought under this license adaptimmune shall expense provide attorney reasonably acceptable indemnified party defend against such claim indemnified party shall cooperate fully with adaptimmune such defense shall permit adaptimmune conduct control such defense disposition such claim including decision relative litigation appeal settlement provided that adaptimmune shall settle such claim with admission liability without prior written approval which shall unreasonably withheld conditioned delayed font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size insurance such time licensed cell product licensed cell method process service relating developed pursuant this license being tested used human subject commercially distributed sold other than purpose obtaining regulatory approval adaptimmune affiliate agent adaptimmune adaptimmune shall sole cost expense procure maintain policy product liability insurance amount than incident annual aggregate naming fhcrc additional insured upon written request adaptimmune shall furnish with certificate insurance evidencing insurance required hereunder adaptimmune elect self insure part font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size limit described above including deductible retention which excess annual aggregate such self insurance program must acceptable minimum amount insurance coverage required under these provision shall construed create limit adaptimmune liability with respect indemnification obligation under section nbsp nbsp this license such policy terminated without thirty prior written notice fhcrc adaptimmune shall provide fhcrc with written evidence insurance copy policy upon request font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size indemnification adaptimmune fhcrc font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune expense shall indemnify defend hold harmless fhcrc respective affiliate respective officer director shareholder employee agent each foregoing each fhcrc indemnified party from against liability incurred imposed upon fhcrc indemnified party connection with third party claim arising connection with resulting from nbsp misrepresentation with regard breach representation warranty adaptimmune forth section nbsp this license nbsp licensed product licensed monoclonal antibody development manufacture distribution sublicensing sale licensed cell product adaptimmune affiliate except extent caused negligence willful misconduct fhcrc including without limitation liability resulting from infringement third party intellectual property right adaptimmune affiliate based foregoing nbsp other activity performed adaptimmune affiliate pursuant this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size indemnification adaptimmune font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size expense shall indemnify defend hold harmless adaptimmune affiliate their respective officer director shareholder employee agent each adaptimmune indemnified party from against liability incurred imposed upon adaptimmune indemnified party connection with third party claim arising connection with this license except each case extent that such claim arises result from nbsp herein nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size adaptimmune indemnified party entitled indemnification hereunder shall provide with prompt written notice claim which indemnification sought under this license shall expense provide attorney reasonably acceptable adaptimmune indemnified party defend against such claim adaptimmune indemnified party shall cooperate fully with such defense shall permit conduct control such defense disposition such claim suit action including decision relative litigation appeal settlement provided that font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size written approval which shall unreasonably withheld conditioned delayed font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size legal action event legal action commenced against involving font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size whether named party legal action shall keep attorney nominee fully advised progress legal action shall reimburse incurred result being called witness therein asked testify consult with connection therewith agrees that will reasonably request cooperate with extent reasonably possible legal action brought pursuant this article nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size confidentiality font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size from effective date until year after termination expiration license each recipient shall font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp nbsp limit dissemination discloser information those recipient affiliate their respective director officer employee agent shareholder subcontractor have reasonable need know such information exercise right perform obligation otherwise font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp maintain information discloser confidence disclose such information third party other than forth section nbsp above font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp such information only extent necessary recipient exercise right perform obligation under this license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font font size style font size font font size style font size notwithstanding provision section nbsp nbsp recipient compelled disclose discloser information order court competent jurisdiction nbsp reasonably necessary reasonable opinion recipient legal counsel disclose information comply with applicable including compliance with applicable security regulation stock exchange nasdaq disclosure requirement reporting purpose then such disclosure extent compelled required shall breach hereunder provided that reasonable advance notice given discloser permit discloser reasonable opportunity obtain applicable governmental judicial protection available like material recipient will reasonably cooperate with discloser expense discloser with respect thereto font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding provision section nbsp adaptimmune disclose information order make filing submission correspond communicate with united state food drug agency clinical registry agency including without limitation european medicine agency emea medicine healthcare product regulatory agency mhra including purpose obtaining authorization conduct clinical trial commercialize licensed cell product pursuant this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune shall information ltcand make foregoing disclosure only extent necessary reasonable opinion such party legal counsel shall reasonable commercial effort obtain confidential treatment such disclosure font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding provision section nbsp adaptimmune disclose information investor potential investor font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune shall make foregoing disclosure only pursuant written executed confidentiality agreement which confidentiality obligation burdensome than those hereunder expressly limiting onward disclosure counterparty financial legal advisor then only under equivalent more burdensome obligation disclosure limited font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size nbsp font font size style font size adaptimmune shall notify writing actual suspected misuse misappropriation unauthorized disclosure fhcrc information that come adaptimmune attention font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding anything contrary contained herein fhcrc information shall include limited fhcrc device cell line monoclonal antibody method process data regarding testing experiment drawing documentation patent application product development plan marked confidential that disclosed adaptimmune hereunder font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size this article nbsp will survive termination expiration this license font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size article nbsp font font size style font size font font size style font size general provision font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size governing dispute resolution font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size this license shall governed construed accordance with each case without reference rule nbsp conflict except that matter pertaining intellectual property right patent shall governed jurisdiction which such intellectual property right patent exist dispute between adaptimmune pertaining interpretation this license breach thereof shall settled binding arbitration city washington administered american arbitration association accordance with commercial arbitration rule judgment award rendered arbitrator entered court having jurisdiction thereof administrative charge arbitrator related expense arbitration shall paid equally party each party shall responsible cost expense incurred presenting such party case arbitrator such attorney expert witness there shall three arbitrator font font size style font size each party shall appoint arbitrator third arbitrator shall presiding arbitrator shall appointed agreement party appointed arbitrator agreement such appointment reached font font size style font size party font font size style font size make appointment font font size style font size arbitration proceeding shall conducted english arbitration tribunal shall apply font font size style font size font font size style font size rule nbsp effect time arbitration event conflict between provision this section nbsp nbsp such rule provision this section nbsp font font size style font size nbsp font font size style font size shall prevail award arbitration tribunal shall final binding upon disputing party winning party cost expense losing party apply court competent jurisdiction enforcement such award administrative charge arbitrator related expense font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size arbitration shall paid equally party each party shall responsible cost expense incurred presenting such party case arbitrator such attorney expert witness font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding party agreement arbitrate party hereby agree that party apply court equity competent jurisdiction specific performance injunctive relief enforce prevent violation provision article nbsp license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size complete agreement amendment font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size upon effectiveness hereof this license constitutes complete understanding agreement between party supersedes prior understanding written oral agreement relative subject matter this license this license amended except instrument writing signed party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size severability font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party intend that provision this license contrary applicable regulation illegality invalidity provision this license shall impair affect invalidate other provision this license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size interpretation heading font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size heading article section this license convenience reference only form part this license shall affect interpretation thereof font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size independent party entity font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size relationship party that independent party agent each other partner participant joint venture each party shall maintain sole exclusive control over their respective personnel operation font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size name font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size adaptimmune agrees refrain from using name fhcrc either their respective affiliate trade name trademark logo affiliate publicity advertising without prior written approval font font size style font size agrees refrain from using name adaptimmune affiliate trade name trademark logo adaptimmune affiliate publicity advertising without prior written approval adaptimmune font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size bankruptcy code font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party acknowledge agree that this license purpose section nbsp nbsp united state bankruptcy code bankruptcy code license font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size right intellectual property defined under section nbsp bankruptcy code party agree that adaptimmune licensee such right under this license subject adaptimmune affiliate full compliance with obligation under this license including obligation royalty abide license restriction shall retain fully exercise right including right enforce exclusivity provision this license including embodiment such intellectual property remedy election under bankruptcy code font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size counterpart facsimile font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this license executed more counterpart each which shall deemed original which together shall constitute same instrument this license executed facsimile signature font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size waiver font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party hereto mutually covenant agree that waiver either party breach default term this license shall deemed waiver subsequent breach default thereof font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size computation time font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whenever last exercise privilege discharge duty hereunder shall fall saturday sunday public legal holiday whether local national party having such privilege duty shall have until nbsp such party time zone next succeeding business exercise such privilege discharge such duty font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size independent party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party this license independent contractor agent other this license shall constitute partnership joint venture neither party bound other contract arrangement understanding except specifically stated herein font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font font size style font size font font size style font size further instrument font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size upon request either party other party agrees execute acknowledge deliver such further instrument such other reasonably necessary appropriate order carry purpose intent this license font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size signature appear following page font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size witness whereof party hereto have caused this license executed their authorized representative this license effective effective date font align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width colspan valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size adaptimmune font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold life technology corporation font font size style font size font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold adaptimmune limited font font size style font size font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp nbsp paul grossman font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp nbsp nbsp nbsp james noble font width valign style padding width style margin font size face time roman style font size font style italic nbsp font width valign style border none padding width align center style margin text align center font size face time roman style font size font style italic signature font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font style italic nbsp font width valign style border none padding width align center style margin text align center font size face time roman style font size font style italic signature font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size typed name nbsp nbsp paul grossman font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size typed name nbsp nbsp nbsp nbsp james noble font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title strategy nbsp corp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size december nbsp font table align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp patent right font align center style margin text align center font size face time roman style font size font weight bold patent font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold serial number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold title font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold inventor font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold status font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold foreign patent font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold serial number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold title font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold inventor font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold status font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold serial number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold title font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold inventor font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold status font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold commercial development plan font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size portion this page nbsp have been omitted pursuant request confidential treatment filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left adaptimmune therapeutic folio file disk _zag user jvangb tocexistflag body html text document